BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell 2016;3:420-37. [PMID: 28357379 DOI: 10.15698/mic2016.09.527] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Duarte G, Pezzuto P, Barros TD, Mosimann Junior G, Martínez-Espinosa FE. [Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis]. Epidemiol Serv Saude 2021;30:e2020834. [PMID: 33729415 DOI: 10.1590/S1679-4974202100016.esp1] [Reference Citation Analysis]
2 Li Q, Lu C, Li W, Huang Y, Chen L. Globulin–platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels. Clin Exp Med 2018;18:71-8. [DOI: 10.1007/s10238-017-0472-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
3 Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 2020;33. [PMID: 32102898 DOI: 10.1128/cmr.00046-19] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 18.5] [Reference Citation Analysis]
4 Li M, Zu J, Shen M, Zhuang G, Chen S, Wang F, Zheng H, Zhang G. Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study. BMC Public Health 2021;21:388. [PMID: 33607996 DOI: 10.1186/s12889-021-10408-5] [Reference Citation Analysis]
5 Inoue T, Tanaka Y. The Role of Hepatitis B Core-Related Antigen. Genes (Basel) 2019;10:E357. [PMID: 31075974 DOI: 10.3390/genes10050357] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
6 Lin S, Zhang YJ. Interference of Apoptosis by Hepatitis B Virus. Viruses 2017;9:E230. [PMID: 28820498 DOI: 10.3390/v9080230] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
7 Yadav S, Verma V, Singh Dhanda R, Yadav M. Insights into the toll-like receptors in sexually transmitted infections. Scand J Immunol 2021;93:e12954. [PMID: 32762084 DOI: 10.1111/sji.12954] [Reference Citation Analysis]
8 Watanabe T, Inoue T, Tanaka Y. Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B. Microorganisms 2021;9:2083. [PMID: 34683404 DOI: 10.3390/microorganisms9102083] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Le TV, Vu TTM, Dang AK, Vu GT, Nguyen LH, Nguyen BC, Tran TH, Tran BX, Latkin CA, Ho CSH, Ho RCM. Understanding Risk Behaviors of Vietnamese Adults with Chronic Hepatitis B in an Urban Setting. Int J Environ Res Public Health 2019;16:E570. [PMID: 30781486 DOI: 10.3390/ijerph16040570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Cooper C, Driedger M, Wong D, Haylock-Jacobs S, Aziz Shaheen A, Osiowy C, Fung S, Doucette K, Wong A, Barrett L, Conway B, Ramji A, Minuk G, Sebastiani G, Wong P, Coffin CS. Distinct Hepatitis B and HIV co-infected populations in Canada. J Viral Hepat 2021;28:517-27. [PMID: 33306853 DOI: 10.1111/jvh.13453] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang S, Tao Y, Tao Y, Jiang J, Yan L, Wang C, Ding Y, Yu J, Zhao D, Chi X, Wang X, Wu R, Gao X, Shi Y, Guan Y, Li Y, Xing Y, Sun H, Ta C, Wang C, Niu J, Meng J, Xu H. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. BMC Public Health 2018;18:1088. [PMID: 30176842 DOI: 10.1186/s12889-018-5984-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Amer F, Yousif MM, Mohtady H, Khattab RA, Karagoz E, Ayaz KFM, Hammad NM. Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection. Int J Infect Dis 2020;92:13-8. [PMID: 31863879 DOI: 10.1016/j.ijid.2019.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Inoue T, Tanaka Y. Novel biomarkers for the management of chronic hepatitis B. Clin Mol Hepatol 2020;26:261-79. [PMID: 32536045 DOI: 10.3350/cmh.2020.0032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
14 Koc Ö, Van Damme P, Busschots D, Bielen R, Forier A, Nevens F, Robaeys G. Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017. Euro Surveill 2019;24. [PMID: 31362809 DOI: 10.2807/1560-7917.ES.2019.24.30.1900064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sira J, Brown M, Ambegaokar S, Modin L, Kelly DA. The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom. J Child Health Care 2019;23:437-45. [PMID: 30818996 DOI: 10.1177/1367493519831499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Le Tortorec A, Matusali G, Mahé D, Aubry F, Mazaud-Guittot S, Houzet L, Dejucq-Rainsford N. From Ancient to Emerging Infections: The Odyssey of Viruses in the Male Genital Tract. Physiol Rev 2020;100:1349-414. [PMID: 32031468 DOI: 10.1152/physrev.00021.2019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
17 Haykir Solay A, Eser F. High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study. Hum Vaccin Immunother. 2019;15:1177-1182. [PMID: 30676860 DOI: 10.1080/21645515.2019.1574151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
18 Ganczak M, Topczewska K, Budnik-Szymoniuk M, Korzeń M. Seroprevalence of anti-HBc, risk factors of occupationally acquired HBV infection and HBV vaccination among hospital staff in Poland: a multicenter study. BMC Public Health 2019;19:298. [PMID: 30866893 DOI: 10.1186/s12889-019-6628-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Iradukunda PG, Habyarimana T, Niyonzima FN, Uwitonze AY, Mpunga T. Risk factors associated with hepatitis B and C in rural population of Burera district, Rwanda. Pan Afr Med J 2020;35:43. [PMID: 32499858 DOI: 10.11604/pamj.2020.35.43.16226] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Baudi I, Inoue T, Tanaka Y. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. Int J Mol Sci. 2020;21. [PMID: 32023902 DOI: 10.3390/ijms21030949] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Duarte G, Pezzuto P, Barros TD, Mosimann Junior G, Martinez-Espinosa FE. Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis. Rev Soc Bras Med Trop 2021;54:e2020834. [PMID: 34008732 DOI: 10.1590/0037-8682-834-2020] [Reference Citation Analysis]
22 Aguilera A, Trastoy R, Rodríguez-Frias F, Muñoz-Bellido JL, Melón S, Suárez A, Orduña A, Viciana I, Bernal S, García-Bujalance S, Montiel N, Molina JM, Basaras M, Fernández-Cuenca F, García-Arata I, Reina G, Ocete MD, Fuentes A, Navarro-de la Cruz D, Nieto L, Blazquez de Castro A, Buti M, Álvarez M, García F. GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016). J Infect 2020;81:600-6. [PMID: 32711039 DOI: 10.1016/j.jinf.2020.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 René A, Quilan M, Deng Y, Cheng Y, Teleha CA, Raboisson P, Bonfanti J, Fortin J, Charette AB, Pannecoucke X, Poisson T, Jubault P. Practical Synthesis of Ethyl 3-Fluoro-1-pyrrole-2-carboxylate: A Key Fragment of a Potent Drug Candidate against Hepatitis B Virus. Org Process Res Dev 2020;24:792-801. [DOI: 10.1021/acs.oprd.9b00382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
24 Mehmankhah M, Bhat R, Anvar MS, Ali S, Alam A, Farooqui A, Amir F, Anwer A, Khan S, Azmi I, Ali R, Ishrat R, Hassan MI, Minuchehr Z, Kazim SN. Structure-Guided Approach to Identify Potential Inhibitors of Large Envelope Protein to Prevent Hepatitis B Virus Infection. Oxid Med Cell Longev 2019;2019:1297484. [PMID: 31772697 DOI: 10.1155/2019/1297484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Fitzpatrick T, Zhou K, Cheng Y, Chan PL, Cui F, Tang W, Mollan KR, Guo W, Tucker JD. A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: study protocol for a nationwide online randomized controlled trial. BMC Infect Dis 2018;18:489. [PMID: 30268114 DOI: 10.1186/s12879-018-3403-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 Sanada T, Yamamoto N, Kayesh MEH, Tsukiyama-Kohara K, Hasegawa H, Miyazaki T, Takano JI, Shiogama Y, Yasutomi Y, Goh Y, Yoshida O, Hiasa Y, Kohara M. Intranasal vaccination with HBs and HBc protein combined with carboxyl vinyl polymer induces strong neutralizing antibody, anti-HBs IgA, and IFNG response. Biochem Biophys Res Commun 2019;520:86-92. [PMID: 31582218 DOI: 10.1016/j.bbrc.2019.09.072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Netanel C, Ben-Aharon O, Ben-Ari Z, Chodick G, Anis E, Magnezi R. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016. Vaccine 2021;39:7101-7. [PMID: 34782158 DOI: 10.1016/j.vaccine.2021.09.072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tufon KA, Meriki HD, Kwenti TE, Tony NJ, Malika E, Bolimo AF, Kouanou YS, Nkuo-Akenji T, Anong DN. HBV Transmission Risk Assessment in Healthcare Workers, Household and Sexual Contacts of HBV Infected Patients in the Southwest Region of Cameroon. Oman Med J 2019;34:313-21. [PMID: 31360320 DOI: 10.5001/omj.2019.62] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
29 Teixeira TA, Oliveira YC, Bernardes FS, Kallas EG, Duarte-Neto AN, Esteves SC, Drevet JR, Hallak J. Viral infections and implications for male reproductive health. Asian J Androl 2021;23:335-47. [PMID: 33473014 DOI: 10.4103/aja.aja_82_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Inoue T, Tanaka Y. Cross-Protection of Hepatitis B Vaccination among Different Genotypes. Vaccines (Basel) 2020;8:E456. [PMID: 32824318 DOI: 10.3390/vaccines8030456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
31 Tomasik A, Pokorska-Śpiewak M, Marczyńska M. Non-Vertical Exposures to HIV, HBV and HCV Infection in Children and Adolescents-Risk of Infection, Standards of Care and Postexposure Prophylaxis. Pediatr Rep 2021;13:566-75. [PMID: 34698220 DOI: 10.3390/pediatric13040067] [Reference Citation Analysis]
32 Khoshdel-Rad N, Zahmatkesh E, Bikmulina P, Peshkova M, Kosheleva N, Bezrukov EA, Sukhanov RB, Solovieva A, Shpichka A, Timashev P, Vosough M. Modeling Hepatotropic Viral Infections: Cells vs. Animals. Cells 2021;10:1726. [PMID: 34359899 DOI: 10.3390/cells10071726] [Reference Citation Analysis]
33 Ji J, Liu L, Jiang F, Wen X, Zhang Y, Li S, Lou J, Wang Y, Liu N, Guo Q, Jia Y, Gao C. The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China. J Clin Lab Anal 2021;35:e24013. [PMID: 34590755 DOI: 10.1002/jcla.24013] [Reference Citation Analysis]
34 Cerón Gómez M, Mondragon EI, Molano PL. Global stability analysis for a model with carriers and non-linear incidence rate. J Biol Dyn 2020;14:409-20. [PMID: 32498626 DOI: 10.1080/17513758.2020.1772998] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Bahuguna P, Prinja S, Lahariya C, Dhiman RK, Kumar MP, Sharma V, Aggarwal AK, Bhaskar R, De Graeve H, Bekedam H. Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India. Appl Health Econ Health Policy 2020;18:393-411. [PMID: 31741306 DOI: 10.1007/s40258-019-00536-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
36 Singh US, Mulamoottil VA, Chu CK. 2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants. Med Res Rev 2018;38:977-1002. [DOI: 10.1002/med.21490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Brandl M, Schmidt AJ, Marcus U, An der Heiden M, Dudareva S. Are men who have sex with men in Europe protected from hepatitis B? Epidemiol Infect 2020;148:e27. [PMID: 32052715 DOI: 10.1017/S0950268820000163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]